Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer

Update your browser to view ScienceDirect.

Request details:

Request ID: 8e56a13528c215c8-LAX
IP: 116.62.10.13
UTC time: 2024-11-20T07:12:05+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4